AKT1 and neoplasm: The oncogenic ALK fusion continuously engages multiple downstream signaling pathways, including PI3K-AKT, RAS-MAPK, and JAK-STAT, thereby promoting tumor cell proliferation, migration, and evasion of apoptosis [39,40].